Literature DB >> 19216684

Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities.

Nancy A Allen1, James A Fain, Barry Braun, Stuart R Chipkin.   

Abstract

BACKGROUND: Continuous glucose monitoring (CGM) has the potential to provide useful data for behavioral interventions targeting non-insulin-using, sedentary individuals with type 2 diabetes mellitus (T2DM). The aims of this study were to describe CGM in terms of (1) feasibility and acceptability and (2) dietary- and exercise-teaching events.
METHODS: Cross-sectional data were analyzed from 27 non-insulin-using adults with T2DM who wore CGM for 72 h as part of a larger study on using CGM for exercise counseling in this population. Feasibility data included accuracy of entering daily self-monitored blood glucose (SMBG) readings and events (e.g., meals, exercise), sensor failures, alarms, optimal accuracy of glucose data, and download failures. Acceptability data included CGM satisfaction and wearing difficulties. Dietary- and exercise-teaching events were identified from CGM and activity monitor data.
RESULTS: CGM graphs showed 141 dietary- and 71 exercise-teaching events. About half the participants (52%) reported difficulty remembering to enter events into CGM monitors, but most (82%) kept an accurate paper log of events. Insufficient SMBG entries resulted in 32 CGM graphs with "use clinical judgment" warnings. Eighty-three percent of missed SMBG entries were from 18 participants 55-77 years old. Missing correlation coefficients resulted from glucose concentrations varying <100 mg/dL. A majority of participants (n = 19) were willing to wear CGM again despite reporting minor discomfort at sensor site and with wearing the monitor.
CONCLUSIONS: CGM data provided several teaching opportunities in non-insulin-using adults with T2DM. Overall, CGM was acceptable and feasible. Some identified problems may be eliminated by newer technology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216684      PMCID: PMC2939842          DOI: 10.1089/dia.2008.0053

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  25 in total

1.  Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.

Authors:  B W Bode; T M Gross; K R Thornton; J J Mastrototaro
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

2.  Dichotomous responses of inter and postprandial hyperglycaemia to short-term calorie restriction in patients with type 2 diabetes.

Authors:  C Colette; C Ginet; C Boegner; M Benichou; T C Pham; J P Cristol; L Monnier
Journal:  Eur J Clin Invest       Date:  2005-04       Impact factor: 4.686

3.  Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements.

Authors:  Richard L Weinstein; Sherwyn L Schwartz; Ronald L Brazg; Jolyon R Bugler; Thomas A Peyser; Geoffrey V McGarraugh
Journal:  Diabetes Care       Date:  2007-03-02       Impact factor: 19.112

4.  A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Authors:  William H Herman; Liza L Ilag; Susan L Johnson; Catherine L Martin; Joyce Sinding; Abdulaziz Al Harthi; Cynthia D Plunkett; Frankie B LaPorte; Ray Burke; Morton B Brown; Jeffery B Halter; Philip Raskin
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

5.  Monitoring exercise-induced changes in glycemic control in type 2 diabetes.

Authors:  Adam L MacDonald; Andrew Philp; Moira Harrison; Adrian J Bone; Peter W Watt
Journal:  Med Sci Sports Exerc       Date:  2006-02       Impact factor: 5.411

6.  Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy.

Authors:  Reinhard Zick; Bettina Petersen; Mario Richter; Cornelia Haug
Journal:  Diabetes Technol Ther       Date:  2007-12       Impact factor: 6.118

7.  Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy.

Authors:  Helen R Murphy; Gerry Rayman; Katherine Duffield; Karen S Lewis; Susan Kelly; Balroop Johal; Duncan Fowler; Rosemary C Temple
Journal:  Diabetes Care       Date:  2007-07-31       Impact factor: 19.112

8.  Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Authors:  Dorothee Deiss; Olga Kordonouri; Reinhard Hartmann; Werner Hopfenmüller; Kerstin Lüpke; Thomas Danne
Journal:  Pediatr Diabetes       Date:  2007-06       Impact factor: 4.866

9.  Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial.

Authors:  Nancy A Allen; James A Fain; Barry Braun; Stuart R Chipkin
Journal:  Diabetes Res Clin Pract       Date:  2008-03-04       Impact factor: 5.602

10.  Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes.

Authors:  Nancy A Allen; Cynthia S Jacelon; Stuart R Chipkin
Journal:  J Clin Nurs       Date:  2009-02       Impact factor: 3.036

View more
  12 in total

1.  The Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World.

Authors:  Ian Blumer
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

2.  Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes".

Authors:  Tejaswi Kompala; Aaron B Neinstein
Journal:  J Diabetes Sci Technol       Date:  2020-10-21

Review 3.  Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.

Authors:  Christine L Chan
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

4.  Flash Continuous Glucose Monitoring: Implications for Use of Continuous Data in Daily Diabetes Management.

Authors:  Irl B Hirsch; Elizabeth Nardacci; Carol A Verderese
Journal:  Diabetes Spectr       Date:  2019-11

Review 5.  Continuous glucose monitoring: a review for behavioral researchers.

Authors:  Julie Wagner; Howard Tennen; Howard Wolpert
Journal:  Psychosom Med       Date:  2012-05       Impact factor: 4.312

6.  Feasibility and acceptability of ambulatory glucose profile in children with Type 1 diabetes mellitus: A pilot study.

Authors:  Sushma Rai; Anjana Hulse; Prasanna Kumar
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

7.  Unacylated ghrelin modulates circulating angiogenic cell number in insulin-resistant states.

Authors:  Behiye Özcan; Pieter J M Leenen; Patric J D Delhanty; Lucy Y Baldéon-Rojas; Sebastian J Neggers; Aart Jan van der Lely
Journal:  Diabetol Metab Syndr       Date:  2017-05-31       Impact factor: 3.320

8.  Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial.

Authors:  Junko Sato; Akio Kanazawa; Fuki Ikeda; Nayumi Shigihara; Minako Kawaguchi; Koji Komiya; Toyoyoshi Uchida; Takeshi Ogihara; Tomoya Mita; Tomoaki Shimizu; Yoshio Fujitani; Hirotaka Watada
Journal:  J Int Med Res       Date:  2015-12-07       Impact factor: 1.671

Review 9.  Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review.

Authors:  Pennie J Taylor; Campbell H Thompson; Grant D Brinkworth
Journal:  J Diabetes Investig       Date:  2018-03-01       Impact factor: 4.232

10.  Using Flash Continuous Glucose Monitoring in Primary Practice.

Authors:  Irl B Hirsch; Eugene E Wright
Journal:  Clin Diabetes       Date:  2019-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.